Theseus Pharmaceuticals, Inc.·4

Nov 14, 4:12 PM ET

CLACKSON TIMOTHY P 4

4 · Theseus Pharmaceuticals, Inc. · Filed Nov 14, 2022

Insider Transaction Report

Form 4
Period: 2022-11-11
CLACKSON TIMOTHY P
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-11-11$6.80/sh+2,500$16,995351,030 total
Footnotes (1)
  • [F1]The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $6.595 to $6.807, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Documents

1 file
  • 4
    tm2230457-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT